# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | RIPK2 inhibitor 5 | 5 | IC50 | = | 10 | nM | ALA4367471 | 8.00 | nM | Homo sapiens | ||
2. | RIPK2 inhibitor 5 | 5 | IC50 | = | 10 | nM | ALA4367470 | 8.00 | nM | Homo sapiens | ||
3. | RIPK2 inhibitor 5 | 5 | IC50 | = | 10 | nM | ALA4367469 | 8.00 | nM | Homo sapiens | ||
4. | RIPK2 inhibitor 5 | 5 | IC50 | = | 10 | nM | ALA4367468 | 8.00 | nM | Homo sapiens | ||
5. | ALA131 | Prednisolone | Activity | 0 | ALA4367475 | Active | Homo sapiens | |||||
6. | ALA131 | Prednisolone | Activity | 0 | ALA4367474 | Active | Homo sapiens | |||||
7. | ALA131 | Prednisolone | Activity | 0 | ALA4367473 | Active | Homo sapiens | |||||
8. | ALA131 | Prednisolone | Activity | 0 | ALA4367472 | Active | Homo sapiens | |||||
9. | RIPK2 inhibitor 5 | 5 | Activity | 0 | ALA4367471 | Dose-dependent effect | Homo sapiens | |||||
10. | RIPK2 inhibitor 5 | 5 | Activity | 0 | ALA4367470 | Dose-dependent effect | Homo sapiens | |||||
11. | RIPK2 inhibitor 5 | 5 | Activity | 0 | ALA4367469 | Dose-dependent effect | Homo sapiens | |||||
12. | RIPK2 inhibitor 5 | 5 | Activity | 0 | ALA4367468 | Dose-dependent effect | Homo sapiens | |||||
13. | ALA131 | Prednisolone | INH | 0 | ALA3824659 | Active | % | Homo sapiens | ||||
14. | ALA131 | Prednisolone | INH | 0 | ALA3824658 | Active | % | Homo sapiens | ||||
15. | ALA131 | Prednisolone | INH | 0 | ALA3824657 | Active | % | Homo sapiens | ||||
16. | ALA131 | Prednisolone | INH | 0 | ALA3824656 | Active | % | Homo sapiens | ||||
17. | GSK 583 | 27 | INH | 0 | ALA3824654 | Dose-dependent effect | % | Homo sapiens | ||||
18. | GSK 583 | 27 | INH | 0 | ALA3824653 | Dose-dependent effect | % | Homo sapiens | ||||
19. | GSK 583 | 27 | INH | 0 | ALA3824652 | Dose-dependent effect | % | Homo sapiens | ||||
20. | GSK 583 | 27 | INH | 0 | ALA3824651 | Dose-dependent effect | % | Homo sapiens |